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Summary 
The ability of two HLA-DR.-expressing human T cell clones to function as antigen-presenting 
ceils (APC) was investigated using highly purified T cells. The results demonstrated that these 
T  cell clones are unable to act as autonomous APC, and that recognition of nominal or allo- 
antigens on the surface of T  cells leads to a state of nonresponsiveness. The first observation 
was that a T cell done with specificity for the 306-324 peptide of influenza hemagglutinin (HA), 
and raised from a DR1 responder, exhibited apparent degeneracy of major histocompatibility 
complex restriction when cultured with peptide in the presence of peripheral blood mononuclear 
cells (PBMC) expressing a wide variety of structurally unrelated DR types. However, when the 
PBMC were pulsed with peptide and washed before cocuhure with the clone, peptide was exclusively 
recognized with DRIDwl. This implied that in the presence of soluble peptide the T cells were 
displaying ligand to each other, and that the third-party APC were providing costimulatory 
signals. To test the ability of T cells to act as autonomous APC, accessory cell-free preparations 
of two DRl-restricted clones were cultured with peptide in the presence or the absence of added 
B cell APC. T cell purity was established by the absence of proliferation in response to the mitogen 
phytohemagglutinin (PHA). PHA-nonresponsive T  cells were completely unable to proliferate 
in response to Peptide alone; furthermore, precuhure of the HA-specific clone, in the complete 
absence of accessory cells, with the same concentration of peptide (1/~g/ml) that induced optimal 
proliferation when presented by conventional APC, led to profound nonresponsiveness.  The same 
phenomenon was also  observed when two of three anti-DR1  alloreactive T  cell clones were 
precuhured with a DRl-expressing T  cell clone. The ability of the DRl-expressing clone to 
induce nonresponsiveness in anti-DR1 clones correlated with recognition of the DR1 alloantigen 
on the DRl-expressing clone. 
C 
D4-positive T cells recognize antigen in the context of 
class II MHC molecules on APC (1). Specialized APC 
such as macrophages, B cells,  and dendritic cells constitu- 
tively express class II MHC molecules (2).  It is well estab- 
lished that a wide variety of other cell types can be induced 
to express MHC class II molecules, however, the consequences 
of antigen presentation by such cells may vary widely. En- 
dothelial cells, for example, appear to be capable of functioning 
as autonomous APC leading to T  cell activation (3, 4).  In 
contrast, presentation of antigen by keratinocytes or MHC 
class II-expressing pancreatic islet cells can lead to T cell non- 
responsiveness, or anergy (5-7).  Human T  cells are MHC 
class II negative at rest, but can be induced to express all three 
class II isotypes after activation in vivo (8) or in vitro (9). 
Human T  cells have been extensively studied as APC, and 
have been reported to be capable of effective antigen presen- 
tation. Mitogen-activated T cells have been shown to stimu- 
late both allogeneic and autologous mixed lymphocyte reac- 
tions (10-12), although the opposite result has been described 
(13).  In addition, presentation of exogenous viral antigens 
(14) and denaturated protein antigens by MHC class II-posi- 
tive T  cells has been described (15).  More recently, LaSalle 
et al. (16) have shown that activated T cells can also present 
Peptides of the autoantigen, myelin basic protein, but not 
the intact antigen, to autologous T cells. The failure to present 
intact antigen in its native conformation is thought to be 
due to the inability of T cells to capture and process antigen 
effciently. In keeping with earlier observations that antigen 
presentation by antigen-specific B cells was several orders of 
magnitude more efficient than by B cells with an irrelevant 
specificity, Lanzavecchia et al. (17) reported that antigen pre- 
sentation by T cells occurred when the antigen bound to and 
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the deficiency ofT cells in antigen processing is quantitative, 
rather than qualitative, and can be overcome when a specific 
mechanism of antigen capture is operative. 
In addition to these reports of T  cells as effective APC, 
apparently conflicting observations have been reported showing 
that recognition of antigen on the surface of T cells can in- 
duce a state of nonresponsiveness.  Indeed, the first observa- 
tion of antigen-specific unresponsiveness  by a T  cell clone 
was reported after the incubation of influenza hemagglutinin 
(HA)-specific human T cells with high concentrations of HA 
peptide antigen in the absence of accessory cells (18). This 
state of "anergy" appeared to be the result of peptide recog- 
nition by T cells on the surface of other members of the clone, 
restricted by their expressed DR molecules. Since this obser- 
vation, many other examples of tolerance induction have been 
described  (19-21).  The conditions that lead to the anergic 
state appear to require an imbalance between TCK occupancy, 
leading to the delivery of signal 1, and the receipt of poorly 
defined "second signals:' TCR occupancy without cell divi- 
sion appears  to have the same result (22). 
As a consequence of these contradictory findings, the func- 
tional significance of class II MHC molecular expression  on 
T cells is unclear.  It could be argued that presentation of an- 
tigen  by  MHC  class  II-positive  T  cells  leads  to  the 
amplification of an immune response;  alternatively, it could 
have the opposite effect due to the induction of anergy. In 
this study the apparent contradiction between the ability of 
T  cells to present antigen effectively, and their capacity to 
induce anergy, is addressed. 
Materials and Methods 
Antigens and Mitogens.  The antigens used in this study were 
formalin-fixed  influenza  A/Texas  virus particles (diluted  from a stock 
preparation of 5 HAU/ml) and whole HA (kindly supplied by Dr. 
J.  Skehel, National  Institute  of Medical Research, Mill  Hill, 
London). The synthetic HA and matrix (MP) peptides were pre- 
pared by solid phase synthesis using standard t-Boc chemistry in 
"T bags" using commercially  available amino acids (Novabiochem, 
Nottingham, UK). The peptides were cleaved from the resin by 
treatment with hydrogen  fluoride.  Purity was determined  by HPLC 
and amino acid analysis. 
PHA was obtained  from Boroughs Wellcome  (Beckenham,  UK), 
and used at a range of  concentrations from 0.2 to 20 #g/ml. When 
PHA proliferative responses are quoted, these correspond to the 
peak proliferative response observed. 
mAbs.  The L243, anti-DRa mAb (23) was affinity purified 
from ascites by separation over a protein A-Sepharose column. 
Cell Lines.  The DAP.3- and DRl-expressing DAP.3 L cell trans- 
fectants (24) were maintained in culture in DMEM supplemented 
with 10% FCS in 25-cm  z tissue culture flasks and subcultured, 
after trypsin treatment,  at a 1:10 dilution twice weekly. 
EBV-transformed lymphoblastoid B cell lines (B-LCLs), from 
the 10th International Histocompatibility  Workshop, were cultured 
in RPMI 1640 supplemented with 10% FCS, 2 mM t-glutamine, 
50 U/ml penicillin, and 50 #g/ml streptomycin in 25-cm  2 flasks, 
and were regularly passaged. 
T Cell Clones.  Clone NF4 was derived from PBMC isolated 
from a DK1Dwl individual. PBMC (107) were cultured with syn- 
thetic peptide HA306-324 (10/~g/ml) in 10 ml RPMI 1640 sup- 
plemented with 10% human serum, 2 mM t-glutamine, 50 U/ml 
penicillin, and 50/zg/ml streptomycin. After 7 d of culture, the 
blast cells were purified on Ficoll-Paque  density separation  medium 
(Pharmacia, Milton IC-ynes, UK) and then restimulated twice at 
weekly intervals with irradiated autologous PBMC and peptide 
HA306-324. T cell clones were obtained by limiting dilution in 
Terasaki plates at one cell/well with 104 irradiated autologous 
PBMC, 1/~g/ml HA306-324 peptide, and 20 U/ml rib2 (Boerin- 
gher Mannheim Biochemicals,  Mannheim, Germany). T cell clone 
HC1 was generated  from a DR1,4 individual  by stimulating PBMC 
with purified influenza HA (5/~g/ml),  and cloning by limiting 
dilution as for NF4. The clones  were maintained  in culture by weekly 
stimulation  with autologous  PBMC, HA306-324 peptide, and rib2. 
To obtain accessory  cell-free preparations of T cells, cells were 
reseeded into new 24-well tissue culture plates on days  3 and 6 post- 
restimulation in order to remove adherent cells. For use in experi- 
ments the cells were purified by isolation on Ficoll-Paque 7 d after 
restimulation and washed four times by slow speed centrifugation 
(210 g, 5 min) before use. 
AUoreactive anti-DR1 T cell clones, G3, Gll, and G12, were 
obtained as described previously (25). The anti-DRw11 clone L5 
was obtained from a DKw17 responder using the same protocol. 
T cell clones were used for functional assays 1 wk after their last 
stimulation. 
T Cell Proliferation Assays.  T cell clones (10 4 cells/well) were 
cultured in the presence of  irradiated PBMC or B-I.CLs (as indi- 
cated in the figure legends) in flat-bottomed microtiter plates, in 
a total volume of 200 #1. DAP.3 L cell transfectants were treated 
with mitomycin  C (65 #g/ml) (Kyowa,  Tokyo,  Japan). For antigen- 
specific responses, the APC were either prepulsed with antigen, 
or soluble antigen was added to the cultures as indicated in the 
figure legends. Wells were pulsed with 1 #Ci of [3H]TdR (Amer- 
sham International, Amersham, UK), after 48 h and the cultures 
harvested onto glass fiber filters 18 h later. Proliferation was mea- 
sured  as  [3H]TdR incorporation  by  liquid  scintillation  spec- 
troscopy. The results are expressed as the mean cpm for triplicate 
cultures. Standard errors were routinely <10%. 
Two.Stage Cultures.for Tolerance  Induction.  T cell  clone NF4 was 
plated out in wells of 24-well plates in the presence of different 
concentrations of peptide HA306-324 (as indicated in the figure 
legends), in a total volume of 500 #1. In the experiments with al- 
loreactive T cell clones, irradiated clone NF4 was cocultured with 
alloreactive T cells at the ratios indicated in the figure legends in 
conical 10-ml tubes (Sterilin, Staffordshire, UK). The L243 mAb 
was added  as purified  antibody to give a final  concentration  of 10-100 
/~g/ml where indicated. After overnight incubation, the cells were 
harvested, washed extensively, and used in proliferation assay as 
described above. 
Results and Discussion 
Apparent Degeneracy in MHC Restriction o  fan Antigen-specific 
T  Cell Clone.  Clone NF4 was raised against HA peptide, 
as described in Materials and Methods, and responded to in- 
activated A/Texas influenza virus, purified HA, and HA pep- 
tide in a dose-dependent manner. The proliferative responses 
of clone NF4 to the optimal concentrations, as indicated in 
parentheses,  of these three preparations of antigen are shown 
in Table 1. The HLA restriction specificity of the done was 
mapped using a pand of PBMC expressing  different HLA 
DR molecules in the presence  of an optimal concentration 
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of MHC Restriction 
Antigen specificity* 
Flu virus  HA  HA306-324 
Med  (50 HA U/ml)  (5 gg/ml)  (1 ttg/ml) 
Clone NF4  177  50,627  31,740  49,860 
PBMC donor (DR. type)* 
NF  RIL  MB  JRB  GL 
(1,  -  )  (2,4)  (3,  -  )  (4,4)  (5,  -  ) 
Med  323  159  338  177  217 
P306-324  55,244  37,257  41,974  45,420  28,628 
Results are expressed  as the mean cpm for triplicate  cultures. 
* 104 T cells (NF4) were cultured with medium alone,  influenza virus, 
intact HA, or HA 306-324 peptide with 105 irradiated  DRl-expressing 
PBMC. 
* 10  s irradiated PBMC expressing the DR types indicated alone, or with 
HA peptide 306-324. 
of peptide.  As  shown in  Table 1,  the T  cell done NF4 
responded in the presence of all the PBMC tested, and ap- 
peared to be capable of using several  unrdated DR. molecules 
as restriction dements. 
To investigate further the MHC restriction of done NF4, 
PBMC from the same donors shown in Table 1 were prein- 
cubated with a range of HA peptide concentrations, washed, 
and placed in culture with NF4 cells. Under these condi- 
tions,  only the PBMC expressing DRIDwl were able to 
stimulate a proliferative response, as shown in Fig. 1. These 
results suggested that the apparent degeneracy of done NF4 
was due to the presentation  of peptide by the T cells them- 
selves with their cell surface DR. molecules. In this context 
the third-party PBMC provided  a source of the requisite 
costimulatory signals. 
These results suggest that considerable caution needs to 
be exercised when attempting to define the MHC restriction 
specificity  of human T cells. This is a particular problem when 
using peptides that require no further processing as antigens. 
It appears that T  cells are inefhcient  at processing antigen 
(17), so that the kind of apparent degeneracy observed here 
is less likely to be seen when intact antigen is used. 
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Figure  1.  Prepulsing  of  the 
APC with peptide reveals  that the 
HA-specific T cell clone, NF4, is 
restricted  ex.clusively by  HLA- 
DR1. PBMC from individuals ex- 
pressing the DR types indicated 
were prepulsed with different con- 
centrations  of HA 306-324 pep- 
tide  (2  h,  37~  PBMC  were 
washed (three times),  irradiated, 
and 10  s were cultured with 104 T 
cells (NF4). 
HA-specific  T  Cells  Are  Unable  to  Act  as  Autonomous 
APC  Results such as those described above indicate clearly 
that activated human T cells are fully capable of displaying 
ligand to other T cells with cell surface MHC class II mole- 
cules. Whether or not T cells can provide the necessary  "second 
signals" required for T cell activation is less dear. Accessory 
cell-free preparations of two HLA-DRl-restricted HA-specific 
T cell clones, NF4 and HC1, were cultured with specific  pep- 
tide with or without added APC. NF4 cells prepared in the 
normal way were included for comparison (Fig. 2). The level 
of accessory  cell contamination of these different preparations 
is illustrated by their maximal levels of proliferation  in re- 
sponse to PHA (0.2-2.0 #g/ml), which were 24,474 (non- 
purified NF4), 238 (purified NF4), and 188 cpm (purified 
HC1). As shown in Fig. 2 a, the accessory  cell-contaminated 
NF4 cells proliferated in response to soluble peptide in the 
absence of added APC. In contrast, the PHA-nonresponsive 
preparations  of NF4 and HC1 did not respond  to soluble 
peptide  alone, but proliferated strongly in the presence of 
DR1-B-LCL  (Fig. 2,  b and c). 
This result suggests that purified T cells are unable to act 
as autonomous APC and is in contrast with the recent data 
of LaSalle et al. (16), who reported that a human T cell clone 
specific for the autoantigen myelin basic protein (MBP) was 
able to present MBP peptide to itself even when contaminating 
accessory  cells had been removed. The difference  between these 
two systems is not dear, but may reflect heterogeneity be- 
tween T cell clones in their ability to provide costimulatory 
signals. 
Antigen Presentation by Accessory Cell-free  T  Cells Induces 
T Cell Tolerance at Low Peptide Concentrations.  Previous  systems 
in which T cell anergy has been induced by exposure to specific 
antigen have used high peptide concentrations (18). Given 
the inability of T cells to provide the signals necessary for 
inducing T cell activation, presentation of low peptide con- 
centrations  should be sufhcient to lead to T  cell tolerance. 
Accessory  cell-free clone NF4 was cultured overnight with 
four different concentrations of  peptide HA306-324 from 0.19 
to 50/~g/ml. The T cells were harvested the next day and 
washed extensively, and transferred to a proliferation  assay 
in the presence of transfectants expressing DR1Dwl pulsed 
with different concentrations  of HA306-324 peptide.  The 
results are presented in Fig. 3, and show that preincubation 
with the same concentration of peptide that led to optimal 
T cell stimulation in the presence of accessory cells (1 #g/ml) 
caused almost total inhibition of the subsequent response to 
DRl-expressing DAP.3 transfectants pulsed with a range of 
peptide concentrations. The effect was antigen-specific  in that 
preincubation  with influenza matrix peptide 17-31 did not 
induce tolerance. Furthermore, preincubation with all of the 
concentrations of HA peptide led to augmentation of the 
11,2 response (data not shown). 
Recognition of DR Alloantigens  on the Surface of T  Cells in 
the Absence of  Accessory Cells Leads to Allospecific Tolerance  The 
possibility that recognition of alloantigen on the surface of 
accessory  cell-free T cells  would lead to tolerance in aUospecific 
responder T  cells was tested using three anti-DR1 human 
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Figure 2.  Accessory free T cells are unable to act as au- 
tonomous APC.  104 T  cells, (a) nonpurified NF4,  (b) 
purified NF4, and (c) purified HC1, were cultured with 
different concentrations of HA 306-324 peptide alone (f-q), 
or with  3  x  104 peptide-pulsed, irradiated, DRl-ex- 
pressing B-LCL (I). 
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Figure 3.  Preincubation of the HA- 
specific T cell done, NF4, with low 
concentrations of HA IX'pride  induces 
anergy.  5  x  105  purified T  cells 
(NF4)  were  precultured  for  18  h 
(370C) with different concentrations 
of peptide, HA 306-324, at 1 #g/ml 
(I) or 7 #g/ml (Q), with an irrele- 
vant influenza matrix peptide, 17-31, 
1/~g/ml ([~) or 7 #g/ml (O), or with 
medium  alone (A).  After  washing 
(three times)  104 T  cells were  cul- 
tured  with  3  x  104  mitomycin 
C-treated,  peptide-pulsed,  DK1- 
expressing DAP.3 transfectant L cells. 
Results are expressed as the mean cpm 
for triplicate cultures. 
Table  2.  The DRl-expressing Clone NF4 Is Recognized by 
Two of Three Anti-DR1  T  Cell Clones 
Kesponder  clone 
Stimulator  Third-party 
cell  PBMC  G3  Gll  G12 
B-LCL  -  50,903  96,421  166,705 
NF4  -  926  1,043  330 
NF4  +  18,023  17,282  3,323 
104 anti-DR 1 T cells (G3, Gll, or G12) were cultured with 105 irradi- 
ated DKl-expressing B-LCL, 10  s irradiated DRl-expressing purified T 
cells (NF4)  alone,  or together  with 105 irradiated third-party PBMC. 
T  cell clones.  To establish that the DRl-expressing T cell 
clone, NF4, was displaying the necessary peptide/DR1 com- 
plex recognized by the alloreactive clones, a proliferation assay 
was  set up,  with and without added third-party DRw17 
PBMC.  As shown in Table 2,  no proliferation occurred in 
the absence of added accessory cells. In the presence of third- 
party DRw17 PBMC, however, NF4 induced 35% and 18% 
of the level of proliferation that was  stimulated by DR1- 
expressing B cell lines for clones G3 and Gll, respectively. 
In contrast, for clone G12, NF4, with added accessory cells, 
stimulated <2% of the control response. These three clones 
were then used in a preincubation assay, and the results cor- 
related with the proliferation data, as shown in Fig. 4. The 
reactivity of G3 and Gll was substantially reduced (Fig. 4, 
a and b), but no reduction was seen for clone G12 (c). The 
specificity of this effect and its DR dependence is also illus- 
trated by the lack of effect when Gll was preincubated with 
a DRw17-expressing  clone,  or when G3 was preincubated 
with NF4 in the presence of anti-DR antibody. 
These  observations raise questions  about  the functional 
significance of HLA class II expression by activated T cells. 
As with MHC class II expression that is induced on any non- 
professional APC type,  two opposite  outcomes  can be en- 
visaged. One possibility is that the appearance of additional 
class II-bearing ceils leads to amplification of an ongoing im- 
mune response, due to the potential for more display of an- 
tigen/MHC molecular complexes.  This may be limited  in 
the case of T cells due to their apparent inefficiency in the 
processing of complex antigens. However, the observations 
made here that allospecific T ceils recognize their ligand on 
the surface of other T cells argues that at least some antigens 
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Figure 4.  The induction of anergy in anti- 
DR1 T ceils due to preincubation with a DR1- 
expressing done correlates with ligand recog- 
nition. 4  x  105 purified anti-DR1 T cells, (a) 
G3, (b) Gll, or (c) G12, were precultured for 
18 h  (370C)  with 8  x  105 irradiated DR1- 
expressing purified T cells (NF4) (O), medium 
alone  (O),  or  8  x  105  irradiated  DK1- 
expressing purified T cells (NF4) in the pres- 
ence  of purified L243  anti-DRo  mAb  (10 
#g/ml final concentration)  (I), or 8  x  105 
irradiated DRw17-expressing purified T cells 
(LS)  (A).  After  washing  (three  times)  104 
anti-DR1 T cells were cultured with different 
doses of irradiated DRl-expressing B-LCL 
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pression by T  cells could have precisdy the opposite effect. 
As shown in the experiments described in this study, in the 
absence of accessory cells, presentation of antigen by T cells 
leads to anergy. It is not clear whether at rites ofT cell prolifer- 
ation in vivo a T  cell can interact exclusively with another 
T  cell, with no receipt of signals from local accessory cells. 
One speculation is that this could occur during the clonal 
expansion of T  cells,  that such T  cells would be likely to 
express class II molecules, and that this may provide a mech- 
anism to make an immune response self limiting. The members 
of a locally proliferating T  cell done may present antigen 
to each other, leading to arrest of further proliferation. The 
fact that Jenkins  and Schwartz  (20)  were  able to  induce 
nonresponsiveness in vivo after the injection of mice with 
1-ethyl-3(3-dimethylaminopropyl)  carbodiimide-treated,  anti- 
gen-beating spleen cells suggests that exclusive interactions 
of the kind that are required to induce anergy can occur in 
vivo. Whether these observations can be applied to the in- 
duction of nonresponsiveness in the context of transplanta- 
tion remains to be investigated. 
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